CASCADE®
Autologous Platelet System
Interest in fibrin clot techniques and the expanded application of growth factors in soft tissue and bone repair have led to the development of the CASCADE® Autologous Platelet System which produces a Platelet-Rich Fibrin Matrix (PRFM) implant. The PRFM implant represents a potentially more precise technique to deliver a more concentrated and volume stable fibrin matrix rich in platelets. It can be delivered arthroscopically and sutured into a repair site to stimulate a healing response. Growth factors within the PRFM remain functionally viable throughout the Cascade process and are continually released over seven days.
Link to this comment:
All Comments (0)